Liquid biopsy approaches to capture tumor evolution and clinical outcomes during cancer immunotherapy
Circulating cell-free tumor DNA (ctDNA) can serve as a real-time biomarker of tumor burden and provide unique insights into the evolving molecular landscape of cancers under the selective pressure of immunotherapy. Tracking the landscape of genomic alterations detected in ctDNA may reveal the clonal...
Saved in:
| Main Authors: | Susan Scott, Mark Sausen, Valsamo Anagnostou, Jennifer Jackson, Vincent Lam, Joseph C Murray, Lavanya Sivapalan, Jenna Vanliere Canzoniero, Blair Landon, Benjamin P. Levy |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-01-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/11/1/e005924.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liquid biopsies coming of age: biology, emerging technologies, and clinical translation- An introduction to the JITC expert opinion special review series on liquid biopsies
by: Valsamo Anagnostou, et al.
Published: (2023-01-01) -
The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancers
by: Ronan J. Kelly, et al.
Published: (2025-02-01) -
Leveraging liquid biopsy to uncover resistance mechanisms and guide personalized immunotherapy
by: Zeinab Dalloul, et al.
Published: (2025-09-01) -
Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patients
by: Aparna Ganesan, et al.
Published: (2025-07-01) -
Liquid biopsies in cancer
by: Hang Yin, et al.
Published: (2025-03-01)